Healthcare Webinars

Explore applications of CRISPR and iPSCs in disease modeling and drug discovery in our upcoming webinar with Synthego and BrainXell.Standardizing cell models is essential for drug discovery and investigating mechanisms influencing disease onset. Using iPSC-derived neurons and glia marks a revolutionary shift in drug discovery, enabling direct study of novel therapeutics on human neurons without relying on primary human tissue. By creating specific neuron and glia subtypes, researchers can delve into disease pathways, comparing edited to control cell lines to aid in developing therapeutics to treat those diseases.To accelerate the drug discovery workflow focused on curing neurodegenerative and neuro-related diseases, Synthego and BrainXell’s partnership is streamlining this workflow by leveraging Synthego’s CRISPR expertise and BrainXell’s mastery of working with iPS cells and neurons to make curing those diseases within reach.

Discover an informative webinar to unravel the complexity of the Clinical Trials Information System (CTIS) and explore the regulatory structure in Europe. Most importantly, let’s discuss whether all the latest changes in the regulatory landscape still position Europe as the number one destination for clinical trials.

In this digital age, technology has opened up new frontiers in healthcare, and diabetes management is no exception. Automated Insulin Delivery (AID) systems have emerged as a game-changer in the way individuals of all ages cope with diabetes. Join us on this enlightening journey as we explore how these innovations reshape the lives of those with diabetes, ensuring better control and a brighter future.

While air pollution is a major public health threat across Africa, public awareness on health effects of air pollution remains limited. Effective communication on the topic to key stakeholders can help to build support for policy measures that result in air quality improvements over time. The goal of this webinar is to examine approaches to enhance uptake of information related to air pollution and health from a variety of perspectives. Speakers will discuss ideas for mobilizing support for interventions on air pollution and showcase best practices for communicating information on air pollution and health with various audiences. This webinar is co-hosted by HEI and C40 Cities. This is the third webinar in a 4-part series designed to foster engagement, collaboration, learning and peer-exchange in relation to research and policy on air quality and health. The webinars are free to attend and will be conducted in English. Slides and recordings will be made available after each webinar.

The Disability Participation and Participation Network (DPCN) are delighted to invite you to our upcoming webinar on “Disabled Persons Organisations (DPOs) and the UNCRPD”. Event Details: Date: 28th November 2023 Time: 7pm - 8:30pm Venue: Zoom Register on this page or email your details to disabilityparticipation@gmail.com. In the lead up to International Day of Persons with Disabilities, this event aims to raise awareness on: * What a DPO is - an overview, acronyms and General Comment 7 * The forms DPOs take * The role of DPOs under the UNCRPD * What DPOs look like internationally * The role of DPOs in consultation monitoring processes. * Challenges facing DPOs in Ireland today * The benefits of joining or working with DPOs The event will be DPO-led from our membership and there will be a panel discussion towards the end of the session with time for Q&A too. We hope this will benefit not only disabled people and DPOs, but also public bodies, decision makers, disability organisations and allies who might want to learn more about DPOs and how they might involve or consult them in their work. Speakers for this event will include: Dr. Robert Sinnott of Voice of Vision Impairment and Adrian Carroll of AsIAm This event will be recorded and ISL will be available. You can email any questions you might have for our panelists to disabilityparticipation@gmail.com.

As an individualized approach to outcome assessment, Goal Attainment Scaling (GAS) is increasingly gaining attention in clinical research and practice. In this engaging webinar, distinguished GAS experts and thought leaders will share their insights, experiences, and best practices in applying GAS within their respective fields. The guest speaker, Dr. Lynne Turner-Stokes, a world-renowned expert in GAS and Professor of Rehabilitation at King’s College London, UK, will discuss her experience and best practices with implementing GAS in rehabilitation, with a focus on techniques to improve the quality of goal setting. Chere Chapman, CEO of Ardea Outcomes, will moderate the discussion and, with Dr. Gunes Sevinc, share Ardea Outcomes’ experience on methods to improve the quality of goal setting in clinical trials.

Join this webinar series to discover how AI enhances diagnostic accuracy and provides prognostic insights and treatment assessment as well as understand the balance between AI-driven innovation and safeguarding patient privacy and data integrity in oncology clinical trials. Participants will learn how electronic clinical outcome assessment (eCOA) equivalence studies have paved the way for accessibility functionality testing for oncology trials, discover accessibility features for scientific assessment on the potential impact on data integrity and hear about future endeavors to make accessibility a reality for trial participants. The series will help viewers understand the unique aspects of assessing cardiac safety within an oncology development program, improve awareness of electrocardiogram (ECG) best practices, comprehend the importance of objective safety measurements with patient-reported outcomes and learn to enable early detection using wearable sensor technology to proactively monitor patients.

The new framework of globally applicable standards for clinical trial data, effective from September 9, 2023. All companies now need to implement the EMA guideline on computerised systems and electronic data in clinical trials if the data will be used to support a marketing authorization in the European Union (EU). Effective on September 9, 2023, the guideline sets forth consolidated requirements on the use of computerized systems, the collection and use of electronic data and introduces a new framework of standards to be upheld by sponsors, investigators and their service providers globally. The new guideline impacts sponsors, investigators and service providers involved in running clinical trials. Join this ICON webinar to gain the knowledge required to achieve compliance with the new regulatory regime, with a strong focus on data accuracy, security and operational efficiency of the trial.

Join us for an informative webinar as we delve into the world of psychedelic trials and the evolving regulatory landscape surrounding these transformative therapies. Explore the promising efficacy of psychedelics like psilocybin, MDMA, 5-methoxy-dimethyltryptamine, and ibogaine in treating conditions such as depression, PTSD, anxiety, and substance use disorder. During this webinar, we will examine the diverse mechanisms of action underlying these psychedelic compounds, discuss the important results observed in clinical trials, highlight the pivotal role of organizations like MAPS (Multidisciplinary Association for Psychedelic Studies) in shaping the regulatory landscape for psychedelic medicines, explore the pipeline of next-generation psychedelic medicines, and gain insights into the recent guidance issued by the US FDA and explore the regulatory pathways for the clinical study and approval of psychedelics in both Australia and the United States.

This webinar is for users with a Zoom account. New to Zoom? Sign up free. Dr. Rodney French: Dr. French is a graduate of UBC Faculty of Medicine (1996) and completed his residency in Plastic Surgery at Dalhousie University (2002). He completed a Masters degree in Surgical Education at Mount Saint Vincent University and Dalhousie University (2003). He completed a one year fellowship in Hand, Wrist and Microsurgery at Harvard University (2004). He has a Diploma in Sports Medicine (2017) from the Canadian Association of Sport and Exercise Medicine (CASEM). In 2021 he completed a Masters Certificate at Harvard in Medicine And The Media. Jean-François Ouellet Jean-François graduated from McGill University with a B Sc. (O.T.) in 2003 and holds a current registration to practice in the province of Quebec as an Occupational Therapist (OEQ member). He has been working in private practices since 2003 exclusively treating elbow, wrist and hand injuries. He has been a Certified Hand Therapist since 2009. He was coordinator of the Montreal Hand Interest Group for 8 years. He worked as an assistant-teacher for orthotic labs at McGill University from 2009 to 2014. He has been an invited speaker at numerous Quebec Hand Surgery Conferences (ASCPEQ) as well as for the Canadian Society of Hand Therapists (CSHT). Jean-François has been mentoring other therapists and has a passion for sharing his knowledge. He regularly teaches wrist and hand examination courses to GPs through GMFs. He also works with professional athletes from various fields and associations (NHL, MLS, UFC, CFL, olympians, performing artists, QMJLH,...). He has joined Kinatex Brossard in 2023. He serves as President for the Canadian Society of Hand Therapist.